Home Infusion Therapy Market Report 2026

The home infusion therapy market size has grown rapidly in recent years. It will grow from $35.64 billion in 2025 to $39.4 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing hospitalization costs, growing prevalence of chronic and infectious diseases, expansion of basic infusion pump availability, rising acceptance of home-based clinical treatments, shortage of inpatient hospital beds.

The home infusion therapy market size is expected to see strong growth in the next few years. It will grow to $57.28 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing use of biologics and specialty pharmaceuticals, rising demand for long-term nutrition and hydration therapy, growing preference for outpatient and home treatment models, expansion of skilled nursing support for home infusion, increasing healthcare cost containment initiatives. Major trends in the forecast period include rising shift from hospital-based to home-based infusion care, increasing adoption of self-administered and nurse-assisted therapies, growth in long-term infusion for chronic and complex conditions, expansion of specialty and high-cost drug administration at home, increasing focus on patient convenience and treatment continuity.

The increasing global population and the resulting rise in food demand are expected to drive the growth of the home infusion therapy market in the coming years. Food, which provides essential nutrients such as proteins, carbohydrates, fats, and other compounds, is critical for patients undergoing home infusion therapy. The growth in population has led to an increase in the number of elderly individuals who require home infusion therapy. For example, in January 2024, the United States Department of Agriculture reported that in 2023, food expenditures accounted for an average of 12.9% of U.S. household spending, slightly up from 12.8% in 2022. Therefore, the rising population and associated food demand are contributing to the expansion of the home infusion therapy market.

Key players in the home infusion therapy market are focusing on innovations such as compact infusion systems to gain a competitive advantage. One example is the Avoset Infusion Platform, a connected, multi-therapy ambulatory infusion system designed to transform post-acute care and specialty infusion therapy. In April 2023, Eitan Medical Ltd., an Israel-based medical device company, launched the Avoset Infusion Platform. The system offers simplified, compact technology, remote monitoring capabilities, and integration with the AvosetGo app to improve patient outcomes, enhance comfort, and support independence throughout the treatment cycle.

In July 2024, Dynamic Infusion, a U.S.-based provider of home infusion nursing services, acquired IV Solutions Group, LLC for an undisclosed amount. This acquisition strengthens Dynamic Infusion’s presence in central and northern New Jersey and aligns with its goal of becoming a leading national platform for home infusion services. IV Solutions Group, LLC, is a U.S.-based provider of home infusion therapy.

Major companies operating in the home infusion therapy market are Option Care Health Inc, KabaFusion Holdings LLC, PromptCare Companies, CSI Pharmacy LLC, Healix Infusion Therapy Inc, InfuCare Rx Inc, Integrated Home Care Services Inc, IVX Health Inc, Nations Home Infusion LLC, Oso Home Care LLC, Palmetto Infusion Services LLC, Penn Home Infusion Therapy, Premier Infusion Care LLC, Basic Home Infusion Inc, ARJ Infusion Services Inc, Beacon Infusion Healthcare Services LLC, CarepathRx LLC, National Pharmacy Services LLC, Kroger Specialty Infusion, Metro Infusion Center.

North America was the largest region in the home infusion therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the home infusion therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the home infusion therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the home infusion therapy market by increasing the cost of imported infusion pumps, intravenous sets, cannulas, and needleless connectors, which are critical components of home-based therapy delivery. These impacts are most pronounced in equipment-intensive segments and in regions such as North America and Europe that rely on global medical device supply chains, particularly from Asia-Pacific manufacturing hubs. Higher input costs may affect pricing and adoption rates; however, tariffs are also encouraging localized manufacturing, supplier diversification, and cost optimization strategies, supporting long-term supply resilience in the market.

The home infusion therapy market research report is one of a series of new reports that provides home infusion therapy market statistics, including home infusion therapy industry global market size, regional shares, competitors with a home infusion therapy market share, detailed home infusion therapy market segments, market trends and opportunities, and any further data you may need to thrive in the home infusion therapy industry. This home infusion therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Home infusion therapy involves the subcutaneous or intravenous administration of drugs or biologicals to patients in their homes. Medications are delivered directly into the veins or beneath the skin using catheters or needles, allowing patients to receive treatment outside of clinical settings.

The main product types in home infusion therapy include infusion pumps, intravenous (IV) sets, IV cannulas, and needleless connectors. Home infusion pumps are medical devices that deliver medications in precise, controlled amounts, regulating the rate of fluid infused into either the blood inflow or outflow lines. Administration routes include intramuscular, subcutaneous, and epidural methods. Home infusion therapy is applied in a variety of treatments, including total parenteral nutrition, anti-infective therapy, enteral nutrition, hydration therapy, chemotherapy, IVIg or specialty pharmaceuticals, and other medical applications. The key end users are patients, nurses, hospitals, and other healthcare providers.

The home infusion therapy market includes revenues earned by entities anti-emetics, catheter maintenance, chemotherapy, hydration, immune globulin therapy, and inotropic therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.